Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Blood Transfusion

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Blood Typing

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Cross-sectional study of respiratory function at adolescence in children born prematurely].

Revue medicale de Liege·2026

Same author

Platelet Additive Solutions and Pathogen Reduction Impact on Transfusion Safety, Patient Management and Platelet Supply.

Transfusion medicine reviews·2025

Same author

[Trust during medical consultations with trans* people].

Revue medicale suisse·2025

Same author

Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.

BMJ medicine·2023

Same author

Erythropoietin downregulates red blood cell clearance, increasing transfusion efficacy in severely anemic recipients.

American journal of hematology·2023

Same author

Eleven years of alloimmunization in 6496 patients with sickle cell disease in France who received transfusion.

Blood advances·2023

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

[Trends in blood transfusion indications].

Anne François¹, Georges Andreu, Philippe Bierling

¹Etablissement français du sang Ile-de-France, 122-130, rue Marcel-Hartmann, 94200 Ivry-sur-Seine, France. anne.francois@efs.sante.fr

La Revue Du Praticien

|March 4, 2009

Summary

Blood component use decreased due to disease transmission fears but has risen since 2006. Increased safety, an aging population, and awareness of under-transfusion risks drive this trend in blood transfusion practices.

Related Experiment Videos

Last Updated: Jun 25, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Area of Science:

Hematology
Transfusion Medicine

Context:

Blood component prescription patterns have significantly evolved.
Initial reductions in use (1986-2002) were driven by concerns over transfusion-transmitted infections.
A notable increase in blood component utilization has been observed since 2003, accelerating from 2006 onwards.

Purpose:

To analyze the trends and driving factors behind changes in blood component prescription.
To understand the shift from reduced usage to increased utilization in transfusion medicine.

Summary:

Blood component use initially declined due to safety concerns but has steadily increased (3-5% annually) since 2006.
Key factors contributing to this resurgence include enhanced transfusion safety measures, including pathogen reduction technologies.
Population aging and a growing understanding of the risks associated with under-transfusion also significantly influence current practices.

Impact:

Highlights the dynamic nature of transfusion medicine and clinical practice guidelines.
Emphasizes the importance of balancing transfusion safety with the clinical need for blood components.
Provides insights into factors shaping future blood transfusion strategies and resource allocation.